Vivek Gupta

6.2k total citations · 2 hit papers
109 papers, 4.9k citations indexed

About

Vivek Gupta is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Vivek Gupta has authored 109 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 30 papers in Molecular Biology and 27 papers in Pharmaceutical Science. Recurrent topics in Vivek Gupta's work include Inhalation and Respiratory Drug Delivery (35 papers), Nanoparticle-Based Drug Delivery (21 papers) and Advanced Drug Delivery Systems (17 papers). Vivek Gupta is often cited by papers focused on Inhalation and Respiratory Drug Delivery (35 papers), Nanoparticle-Based Drug Delivery (21 papers) and Advanced Drug Delivery Systems (17 papers). Vivek Gupta collaborates with scholars based in United States, India and Egypt. Vivek Gupta's co-authors include Samir Mitragotri, Vineela Parvathaneni, Aaron C. Anselmo, Nishant S. Kulkarni, Fakhrul Ahsan, Aaron Muth, Snehal K. Shukla, Brijeshkumar Patel, Bhuvaneshwar Vaidya and Erkki Ruoslahti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and PLoS ONE.

In The Last Decade

Vivek Gupta

105 papers receiving 4.9k citations

Hit Papers

Using shape effects to target antibody-coated nanoparticl... 2013 2026 2017 2021 2013 2019 100 200 300 400 500

Peers

Vivek Gupta
Vivek Gupta
Citations per year, relative to Vivek Gupta Vivek Gupta (= 1×) peers Lisa M. Kaminskas

Countries citing papers authored by Vivek Gupta

Since Specialization
Citations

This map shows the geographic impact of Vivek Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Gupta more than expected).

Fields of papers citing papers by Vivek Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Gupta. The network helps show where Vivek Gupta may publish in the future.

Co-authorship network of co-authors of Vivek Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Gupta. A scholar is included among the top collaborators of Vivek Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Gupta. Vivek Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chauhan, Gautam, et al.. (2024). Chitosan/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs. International Journal of Biological Macromolecules. 271(Pt 2). 132526–132526. 7 indexed citations
3.
Wang, Xuechun, et al.. (2024). Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment – Evidence in disease-relevant in-vitro models. Journal of Drug Delivery Science and Technology. 95. 105615–105615. 12 indexed citations
4.
Kanabar, Dipti, et al.. (2024). Synthesis and Evaluation of 2,5-Substituted Pyrimidines as Small-Molecule Gankyrin Binders. Future Medicinal Chemistry. 16(3). 239–251.
5.
Gadhave, Dnyandev, et al.. (2023). A Nanoemulgel for Nose-to-Brain delivery of Quetiapine – QbD-Enabled formulation development & in-vitro characterization. International Journal of Pharmaceutics. 648. 123566–123566. 12 indexed citations
6.
Chauhan, Gautam, Xuechun Wang, Carol Yousry, & Vivek Gupta. (2023). Scalable Production and In Vitro Efficacy of Inhaled Erlotinib Nanoemulsion for Enhanced Efficacy in Non-Small Cell Lung Cancer (NSCLC). Pharmaceutics. 15(3). 996–996. 28 indexed citations
7.
Parvathaneni, Vineela, Snehal K. Shukla, & Vivek Gupta. (2023). Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment. Pharmaceutics. 15(3). 1001–1001. 26 indexed citations
8.
Wang, Xuechun, et al.. (2023). Surface-Modified Inhaled Microparticle-Encapsulated Celastrol for Enhanced Efficacy in Malignant Pleural Mesothelioma. International Journal of Molecular Sciences. 24(6). 5204–5204. 7 indexed citations
9.
Parvathaneni, Vineela, Rameswari Chilamakuri, Nishant S. Kulkarni, et al.. (2022). Repurposing clofazimine for malignant pleural mesothelioma treatment — In-vitro assessment of efficacy and mechanism of action. Life Sciences. 306. 120843–120843. 3 indexed citations
10.
Kulkarni, Nishant S., Bhuvaneshwar Vaidya, & Vivek Gupta. (2021). Nano-synergistic combination of Erlotinib and Quinacrine for non-small cell lung cancer (NSCLC) therapeutics – Evaluation in biologically relevant in-vitro models. Materials Science and Engineering C. 121. 111891–111891. 14 indexed citations
11.
Gupta, Vivek, Rahul Thakur, & Amit Baran Das. (2021). Effect of natural deep eutectic solvents on thermal stability, syneresis, and viscoelastic properties of high amylose starch. International Journal of Biological Macromolecules. 187. 575–583. 25 indexed citations
12.
Kanabar, Dipti, et al.. (2020). Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30(17). 127372–127372. 9 indexed citations
13.
Parvathaneni, Vineela & Vivek Gupta. (2020). Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges. Life Sciences. 259. 118275–118275. 95 indexed citations
14.
Panni, Roheena Z., John M. Herndon, Brett L. Knolhoff, et al.. (2018). CD11b hyperactivation improves response to immunotherapy in pancreatic cancer. HPB. 20. S536–S537. 1 indexed citations
15.
Wibroe, Peter P., Aaron C. Anselmo, Per H. Nilsson, et al.. (2017). Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nature Nanotechnology. 12(6). 589–594. 165 indexed citations
16.
Vaidya, Bhuvaneshwar & Vivek Gupta. (2015). Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery. Journal of Controlled Release. 211. 118–133. 35 indexed citations
17.
Jeong, Sun‐Young, Megan Sjodt, Cary Retterer, et al.. (2015). Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting. Scientific Reports. 5(1). 13476–13476. 30 indexed citations
18.
Gupta, Vivek, et al.. (2009). Investigations on cellular interaction of polyelectrolyte based nano-walled reservoir using MCF-7 cell lines: a novel chemotherapeutic approach. Journal of Pharmacy and Pharmacology. 61(12). 1601–1607. 5 indexed citations
19.
Bai, Shuhua, Vivek Gupta, & Fakhrul Ahsan. (2009). Inhalable Lactose-Based Dry Powder Formulations of Low Molecular Weight Heparin. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(2). 97–104. 23 indexed citations
20.
Gupta, Vivek, et al.. (1995). Extractants and Critical Limit for Available Sulphur in Aridisols. Journal of the Indian Society of Soil Science. 43(3). 478–479. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026